Zydus Cadila has received the final approval from the USFDA to market Atenolol and Chlorthalidone Tablets USP (US RLD - Tenoretic®), 50 mg/25 mg and 100 mg/25 mg. It will be manufactured at the group's formulations manufacturing facility at SEZ, Ahmedabad.
This medication is used to treat high blood pressure (hypertension). Lowering high blood pressure helps prevent strokes, heart attacks and kidney problems. Atenolol belongs to a class of drugs known as beta blockers. It works by blocking the action of certain natural chemicals in your body, such as epinephrine on the heart and blood vessels. This effect lowers the heart rate, blood pressure and strain on the heart. Chlorthalidone is a 'water pill' (diuretic) and causes the body to get rid of extra salt and water. It also helps to relax the blood vessels so that blood can flow easily.
The group now has 253 approvals and has so far filed over 330 ANDAS since the commencement of the filing process in FY 2003-04.
Shares of CADILA HEALTHCARE LTD. was last trading in BSE at Rs.333 as compared to the previous close of Rs. 325.35. The total number of shares traded during the day was 55866 in over 699 trades.
The stock hit an intraday high of Rs. 333.25 and intraday low of 326.15. The net turnover during the day was Rs. 18495470.